Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Follow-up Programme for Patients Using Symbicort SMART in Normal Clinical Practice

NCT00505388 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00505388
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00505388 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Follow-up Programme for Patients Using Symbicort SMART in Normal Clinical Practice
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
July 31, 2007
Completion date
April 30, 2010
Enrollment
5,137 (actual)
Sites
695

Conditions

As the registry lists them; a condition with its own page is linked.

bronchial asthma